Cargando…
Target Validation: Linking Target and Chemical Properties to Desired Product Profile
The discovery of drugs is a lengthy, high-risk and expensive business taking at least 12 years and is estimated to cost upwards of US$800 million for each drug to be successfully approved for clinical use. Much of this cost is driven by the late phase clinical trials and therefore the ability to ter...
Autores principales: | Wyatt, Paul G, Gilbert, Ian H, Read, Kevin D, Fairlamb, Alan H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers Ltd
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3182078/ https://www.ncbi.nlm.nih.gov/pubmed/21401506 http://dx.doi.org/10.2174/156802611795429185 |
Ejemplares similares
-
Chemical Validation of Trypanothione Synthetase: A POTENTIAL DRUG TARGET FOR HUMAN TRYPANOSOMIASIS
por: Torrie, Leah S., et al.
Publicado: (2009) -
Chemical and genetic validation of dihydrofolate reductase–thymidylate synthase as a drug target in African trypanosomes
por: Sienkiewicz, Natasha, et al.
Publicado: (2008) -
Chemical Validation of Methionyl-tRNA Synthetase as
a Druggable Target in Leishmania donovani
por: Torrie, Leah S., et al.
Publicado: (2017) -
Pharmacological Validation of N-Myristoyltransferase
as a Drug Target in Leishmania donovani
por: Corpas-Lopez, Victoriano, et al.
Publicado: (2018) -
Chemical, genetic and structural assessment of pyridoxal kinase as a drug target in the African trypanosome
por: Jones, Deuan C, et al.
Publicado: (2012)